Dss expands its healthcare segment through investment in vivacitas oncology

Rochester, n.y., april 08, 2021 (globe newswire) -- document security systems, inc. (“dss” or the “company”) (nyse american: dss), a multinational company operating businesses focusing on brand protection technology, blockchain security, direct marketing, healthcare, real estate, and securitized digital assets, today announced dss biomedical international, inc. (“dss biomedical”), a subsidiary of impact biomedical, inc., a wholly owned subsidiary of the company, completed an equity investment in vivacitas oncology, inc. (“vivacitas”), a clinical-stage company focused on difficult to treat cancers.
DSS Ratings Summary
DSS Quant Ranking